Percent relative survival rates. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Cells, Cultured Bile Ducts, Intrahepatic Lymph Nodes

Organisms3

Mice, Inbred C57BL Mice, Inbred BALB C Mice, Knockout

Diseases52

Neoplasms Breast Neoplasms Colorectal Neoplasms Lung Neoplasms Stomach Neoplasms Adenocarcinoma Prostatic Neoplasms Neoplasm Recurrence, Local Liver Neoplasms Lymphatic Metastasis Recurrence Carcinoma, Squamous Cell Carcinoma, Hepatocellular Postoperative Complications Neoplasm Metastasis Disease Progression Carcinoma, Non-Small-Cell Lung Brain Neoplasms Neoplasm Invasiveness Pancreatic Neoplasms Esophageal Neoplasms Carcinoma Disease Models, Animal Bone Neoplasms Heart Arrest Bile Duct Neoplasms Rectal Neoplasms Sarcoma Melanoma Cholangiocarcinoma Ovarian Neoplasms Head and Neck Neoplasms Kidney Failure, Chronic Kidney Neoplasms Prosthesis Failure Osteosarcoma Lymphoma, Non-Hodgkin Glioblastoma Nasopharyngeal Neoplasms Acute Disease Carcinoma, Small Cell Liver Failure Skin Neoplasms Colonic Neoplasms Cadaver Mouth Neoplasms Carcinoma, Renal Cell Hodgkin Disease Glioma Soft Tissue Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Multiple Myeloma

Chemicals and Drugs25

Antineoplastic Agents Tumor Markers, Biological Cisplatin Cyclophosphamide Doxorubicin Vincristine Fluorouracil Prednisone Etoposide Immunosuppressive Agents Deoxycytidine Vinblastine Antimetabolites, Antineoplastic Methotrexate Carboplatin Paclitaxel Antibodies, Monoclonal Bleomycin RNA, Messenger Cryoprotective Agents Cytarabine Dacarbazine Ifosfamide Proto-Oncogene Proteins Survival of Motor Neuron 1 Protein

Analytical, Diagnostic and Therapeutic Techniques and Equipment90

Survival Rate Registries SEER Program Survival Analysis Incidence Prognosis Neoplasm Staging Treatment Outcome Retrospective Studies Follow-Up Studies Disease-Free Survival Cause of Death Life Tables Proportional Hazards Models Combined Modality Therapy Risk Factors Multivariate Analysis Cohort Studies Mortality Probability Kaplan-Meier Estimate Death Certificates Life Expectancy Risk Assessment Regression Analysis Population Surveillance Antineoplastic Combined Chemotherapy Protocols Data Interpretation, Statistical Prospective Studies Actuarial Analysis Chemotherapy, Adjuvant Liver Transplantation Immunohistochemistry Hepatectomy Radiotherapy, Adjuvant Reoperation Drug Administration Schedule Kidney Transplantation Predictive Value of Tests Remission Induction Radiotherapy Dosage Lymph Node Excision Transplantation, Homologous Chi-Square Distribution Disease Models, Animal Gastrectomy Neoadjuvant Therapy Cardiopulmonary Resuscitation Analysis of Variance Chemoembolization, Therapeutic Radiotherapy Salvage Therapy Treatment Failure Patient Selection Cryopreservation Severity of Illness Index Dose Fractionation Chemoradiotherapy Palliative Care Prosthesis Failure Reverse Transcriptase Polymerase Chain Reaction Pneumonectomy Esophagectomy Radiotherapy, High-Energy Risk Brachytherapy Preoperative Care Neoplasm Grading Logistic Models Drug Therapy, Combination Clinical Trials as Topic Heart Transplantation Pancreas Transplantation Tomography, X-Ray Computed Infusions, Intravenous Transplantation, Autologous Tumor Burden Prosthesis Design Statistics, Nonparametric Blotting, Western Randomized Controlled Trials as Topic Random Allocation Renal Dialysis Postoperative Care Gene Expression Profiling Hospital Mortality Hematopoietic Stem Cell Transplantation Feasibility Studies Bone Marrow Transplantation Case-Control Studies

Phenomena and Processes18

Cell Survival Time Factors Graft Survival Probability Apoptosis Graft Rejection Signal Transduction Chi-Square Distribution Cell Proliferation Dose-Response Relationship, Drug Gene Expression Regulation, Neoplastic Mutation Pregnancy Tissue Survival Risk Microbial Viability Longevity Drug Resistance, Neoplasm

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena5

Age Distribution Survival Sex Distribution Socioeconomic Factors Quality of Life

Humanities1

Quality of Life

Information Science12

Survival Rate Registries SEER Program Incidence Cause of Death Life Tables Mortality Death Certificates Life Expectancy Data Interpretation, Statistical Databases, Factual Hospital Mortality

Named Groups5

Survivors Infant, Newborn European Continental Ancestry Group Tissue Donors Living Donors

Health Care49

Survival Rate Registries SEER Program Survival Analysis Incidence Age Distribution Age Factors Treatment Outcome Retrospective Studies Follow-Up Studies Disease-Free Survival Cause of Death Life Tables Proportional Hazards Models Sex Factors Sex Distribution Risk Factors Multivariate Analysis Cohort Studies Mortality Probability Kaplan-Meier Estimate Death Certificates Life Expectancy Risk Assessment Regression Analysis Population Surveillance Data Interpretation, Statistical Socioeconomic Factors Prospective Studies Actuarial Analysis Predictive Value of Tests Chi-Square Distribution Analysis of Variance Treatment Failure Patient Selection Severity of Illness Index Palliative Care Risk Preoperative Care Logistic Models Clinical Trials as Topic Statistics, Nonparametric Randomized Controlled Trials as Topic Random Allocation Postoperative Care Hospital Mortality Feasibility Studies Case-Control Studies

Geographicals12

United States Sweden Finland Western Australia France Europe Philippines Netherlands England Germany Canada Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Survival Rate Registries SEER Program Survival Analysis Incidence Prognosis Age Distribution Neoplasms Age Factors Neoplasm Staging United States Cell Survival Time Factors Treatment Outcome Retrospective Studies Follow-Up Studies Disease-Free Survival Cause of Death Life Tables Sweden Breast Neoplasms Finland Proportional Hazards Models Western Australia Combined Modality Therapy Survival Sex Factors Graft Survival Sex Distribution Risk Factors Colorectal Neoplasms Multivariate Analysis Lung Neoplasms France Cohort Studies Europe Mortality Philippines Probability Kaplan-Meier Estimate Survivors Netherlands Stomach Neoplasms Adenocarcinoma Death Certificates Life Expectancy England Prostatic Neoplasms Germany Risk Assessment Infant, Newborn European Continental Ancestry Group Regression Analysis Population Surveillance Antineoplastic Combined Chemotherapy Protocols Neoplasm Recurrence, Local Data Interpretation, Statistical Databases, Factual Canada Socioeconomic Factors Liver Neoplasms Prospective Studies Actuarial Analysis Lymphatic Metastasis Chemotherapy, Adjuvant Antineoplastic Agents Tumor Markers, Biological Recurrence Liver Transplantation Cisplatin Apoptosis Carcinoma, Squamous Cell Carcinoma, Hepatocellular Postoperative Complications Neoplasm Metastasis Immunohistochemistry Disease Progression Hepatectomy Radiotherapy, Adjuvant Carcinoma, Non-Small-Cell Lung Cyclophosphamide Doxorubicin Vincristine Reoperation Fluorouracil Drug Administration Schedule Kidney Transplantation Predictive Value of Tests Remission Induction Brain Neoplasms Radiotherapy Dosage Neoplasm Invasiveness Pancreatic Neoplasms Cell Line, Tumor Graft Rejection Esophageal Neoplasms Carcinoma Lymph Node Excision Transplantation, Homologous Signal Transduction

No FAQ available that match "percent relative survival rates"